Clinical trial
A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C…
NCT00389896 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00389896 |
|---|---|
| Title | A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Balanced, Three-Way Crossover Study to Evaluate the Efficacy of Simvastatin Therapy in Elevating HDL-C Levels in Patients With Type 2 Diabetic Dyslipidemia and Low HDL-C |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HDL Cholesterol |
| Intervention type | Drug |
| Interventions | MK0733 / Duration of Treatment: 18 Weeks, Comparator: placebo (unspecified) / Duration of Treatment: 18 Weeks |
| Enrollment | 150 |
| Start date | Jul 26, 2001 |
| Primary completion | Oct 4, 2002 |
| Completion | Oct 4, 2002 |
| First posted | Oct 19, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: